{"url_path":"/sec/mbot/8-k/2026-07-21/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-034014-index.html","accession_number":"0001493152-26-034014","cik":"0000883975","ticker":"MBOT","issuer_name":"Microbot Medical Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-034014-index.html","primary_entity_key":"0000883975","primary_entity_name":"Microbot Medical Inc."},"word_count":305,"has_tables":true,"body_markdown":"false\n0000883975\n\n0000883975\n\n2026-07-21\n2026-07-21\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**Washington,\nD.C. 20549**\n\n \n\n**FORM\n8-K**\n\n \n\n**CURRENT\nREPORT**\n\n**Pursuant\nto Section 13 or 15(d)**\n\n**of\nthe Securities Exchange Act of 1934**\n\n \n\n**Date\nof Report (Date of earliest event reported): July 21, 2026**\n\n \n\n**MICROBOT\nMEDICAL INC.**\n\n**(Exact\nname of registrant as specified in its charter)**\n\n \n\n**Delaware**\n \n**000-19871**\n \n**94-3078125**\n\n**(State\nor other jurisdiction**\n\n**of\nincorporation)**\n\n \n\n**(Commission**\n\n**File\nNumber)**\n\n \n\n**(IRS\nEmployer**\n\n**Identification\nNo.)**\n\n \n\n**175\nDerby St., Bld. 27**\n\n**Hingham,\nMA 02043**\n\n**(Address\nof Principal Executive Offices) (Zip Code)**\n\n \n\n**Registrant’s\ntelephone number, including area code: (781) 875-3605**\n\n \n\n \n\n**(Former\nName or Former Address, if Changed Since Last Report)**\n\n \n\nCheck\nthe appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under\nany of the following provisions:\n\n \n\n☐\nWritten communications\npursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n \n\n☐\nSoliciting material pursuant\nto Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n \n\n☐\nPre-commencement communications\npursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n \n\n☐\nPre-commencement communications\npursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Act:\n\n \n\n**Title\nof each class**\n \n**Trading\nSymbol(s)**\n \n**Name\nof each exchange on which registered**\n\nCommon Stock, $0.01 par\nvalue\n \nMBOT\n \nNASDAQ\nCapital Market\n\n \n\nIndicate\nby check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)\nor Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).\n\n \n\nEmerging\nGrowth Company ☐\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}